bpc 157 case report adverse event human Five reasons adding peptides to the 503A bulk compounding lists may be more problematic than you realize – Partnership for Safe Medicines BPC-157 – Research Peptide |

It transfers risk from the development pipeline directly onto patients, without their informed consent, because the information required for consent doesn't exist yet

When patients present with concerning symptoms whilst taking B12 supplements, alternative diagnoses should be considered, including allergic reactions to supplement excipients, interactions with other medications, or coincidental illness

doi: 10.3389/fmed.2023.1098047 Received 17 November 2022 Accepted 02 January 2023 Published 23 January 2023 Volume 10 - 2023 Edited by Manuel Pedro Pereira, Charit Universittsmedizin Berlin, Germany Reviewed by Jan Mauno Ehrchen, University of Mnster, Germany

These autoantibodies form immune complexes that deposit in tissues, triggering complement activation and chronic inflammation